A review of incidence and mortality of colorectal, lung, liver, thyroid, and bladder cancers in Iran and compared to other countries

B Farhood, B Raei, R Malekzadeh, M Shirvani… - Contemporary …, 2019 - termedia.pl
Based on GLOBOCAN 2012, cancers have led to more than 14 million new cases and over
8 million deaths worldwide. The fraction of developing nations is estimated to be 56.9% for …

Cancer incidence in Iran in 2014: results of the Iranian National Population-based Cancer Registry

G Roshandel, A Ghanbari-Motlagh, E Partovipour… - Cancer …, 2019 - Elsevier
Background We aimed to report, for the first time, the results of the Iranian National
Population-based Cancer Registry (INPCR) for the year 2014. Methods Total population of …

Bladder cancer in Iran: an epidemiological review

K Kalan Farmanfarma, N Mahdavifar… - Research and Reports …, 2020 - Taylor & Francis
Purpose Bladder cancer is the sixth most common cancer in Iran. Information about the
epidemiological situation of the disease and its risk factors is necessary for conducting a …

[HTML][HTML] Cancer patterns in Iran: a gender-specific spatial modelling of cancer incidence during 2014–2017

S Faramarzi, B Kiani, S Faramarzi, N Firouraghi - BMC cancer, 2024 - Springer
Background Cancer is a significant public health concern and the second leading cause of
death. This study aims to visualize spatial patterns of top common cancer types and identify …

[HTML][HTML] TERT promoter mutations as simple and non-invasive urinary biomarkers for the detection of urothelial bladder cancer in a high-risk region

H Pakmanesh, O Anvari, N Forey… - International Journal of …, 2022 - mdpi.com
Bladder cancer (BC) is the 10th most common cancer in the world. While there are FDA-
approved urinary assays to detect BC, none have demonstrated sufficient sensitivity and …

Opium use and risk of bladder cancer: a multi-centre case-referent study in Iran

M Hadji, H Rashidian, M Marzban… - International Journal …, 2022 - academic.oup.com
Background Bladder cancer (BC) is the 10th most common type of cancer worldwide and the
fourth most common type of cancer in Iran. Opium use is considered as one of the risk …

[HTML][HTML] Survey of mast cell density in transitional cell carcinoma

HM Tabriz, M Obohat, F Vahedifard… - Iranian journal of …, 2021 - ncbi.nlm.nih.gov
Methods: Fifty-one cases with TCC were selected, and MCD was determined by
immunohistochemistry (IHC) and Giemsa staining. Mortality rate and tumor recurrence were …

Genetic and molecular biology of bladder cancer among Iranian patients

M Mojarrad, M Moghbeli - Molecular genetics & genomic …, 2020 - Wiley Online Library
Background Bladder cancer (BC) is the sixth common cancer among Iranians. Various risk
factors such as smoking, body mass index, chronic infection, age, and genetic factors are …

[HTML][HTML] Preliminary study of prevalence for bladder cancer in Isfahan Province, Iran

H Mazdak, Z Tolou-Ghamari - Arab Journal of Urology, 2018 - Elsevier
Objectives To clarify period prevalence (PP), incidence rate (Ir), and reported mortality for
patients with bladder cancer (BC) in Isfahan Province/Iran, as BC is the most common …

[HTML][HTML] Diagnostic accuracy of NMP 22 and urine cytology for detection of transitional cell carcinoma urinary bladder taking cystoscopy as gold standard

MT Sajid, MR Zafar, H Ahmad, S Ullah… - Pakistan Journal of …, 2020 - ncbi.nlm.nih.gov
Objective: To determine diagnostic accuracy of NMP 22 and urine cytology in the detection
of transitional cell carcinoma (TCC) urinary bladder taking cystoscopy as a gold standard in …